CIMA Sciences, LLC is a biotechnology company focused in bringing to the scientific community and US population the best non-invasive diagnostic technology for high prevalence disease.
Our Story
Founded in 2022 with headquarters in San Antonio, Texas, CIMA Sciences is dedicated to advancing non-invasive diagnostic solutions for widespread medical conditions. With a focus on liver and cardiovascular health, our mission is to equip healthcare providers and researchers with innovative tools that enable earlier detection, improved patient outcomes, and more efficient clinical decision-making.
By combining cutting-edge biotechnology with rigorous scientific research, CIMA Sciences develops diagnostics that are both clinically meaningful and easy to implement. Our flagship test, OWLiver®, exemplifies this approach—providing a fast, reliable, and non-invasive method to assess all stages of MASLD. Through innovation and collaboration, we aim to close critical gaps in early disease detection and support a higher standard of care across the healthcare system.
Partnership With Rubió Metabolomics
The OWLiver® Test was originally developed by Rubió Metabolomics following extensive metabolomics analysis and preclinical research. The development and validation of the OWLiver® test was based on a multicenter and multiethnic study, that included patients with a body mass index exceeding 25 kg/m² and various degrees of type 2 diabetes mellitus, including non-diabetics, controlled diabetics, and diabetics with poor glycemic control.
The OWLiver® Test is a CE-marked in vitro diagnostic medical device, complying with Directive 98/79/EC. It is based on a retrospective study in which patients had previously been diagnosed using the gold standard for this disease, liver biopsy.
Rubió Metabolomics is a global provider of metabolomics services to the pharmaceutical industry, primarily focused on supporting clinical trials in liver diseases and other prevalent human diseases. It also focuses on research in indications where metabolomics plays a key role, including drug therapy monitoring and biomarker discovery.
Advancing Non-Invasive Diagnostics.
Contact Us
300E Sonterra Blvd., Suite 1110
San Antonio, Texas 78258
Order OWLiver® Test
OWLiver® is a non-invasive blood test to assess MASLD. It analyzes a panel of biomarkers through metabolomics methodology.